Skip to content
mindbodybusiness

mindbodybusiness

The business effect

Primary Menu
  • Business Finance & Support
  • Business & Finance News
  • Financial Function
  • Business Effective
  • Business Market
  • Largest Business
  • About Us
    • Advertise Here
    • Contact Us
    • Privacy Policy
    • Sitemap
  • Home
  • Oyster Therapeutics Stock: State Of Business Is Confounding (NASDAQ:OYST)
  • Business Effective

Oyster Therapeutics Stock: State Of Business Is Confounding (NASDAQ:OYST)

By Jackie Patricia 3 years ago

Table of Contents

Toggle
  • Financials
  • Bottom Line
  • About the TPT service

Oyster Therapeutics Stock: State Of Business Is Confounding (NASDAQ:OYST)

Jonathan Knowles/DigitalVision through Getty Visuals

Oyster Stage Pharma, Inc. (NASDAQ:OYST) has an authorised solution, Tyrvaya (OC-01, varenicline solution) Nasal Spray for treating dry eye ailment, and it is also in the pipeline for Neurotrophic Keratopathy Phase 1. NK is a rare disease characterised by lessened corneal sensitivity and very poor corneal therapeutic. For the pipeline program, the company says in its earnings phone:

We carry on to enroll clients in our OLYMPIA Period 2 review of OC-01 nasal spray aimed at managing Phase 1 NK. We continue to be on keep track of to anticipate outcomes of this demo in the 2nd 50 percent of this year.

Now, coming to the acceptance, Tyrvaya was approved in October 2021 and commenced in the marketplace by early November. So this was effectively the to start with comprehensive quarter of claimed earnings for Tyrvaya.

Dry eye disorder takes place in in excess of 38 million People. Latest treatment method alternatives are Allergan’s Restasis and Shire’s Xiidra equally are specified as eye drops. Restasis is a gentle immunosuppressant although Xiidra is an anti-inflammatory drug. Even so, offered the formulation that involves giving the medicines immediately to the eye – often a cumbersome and unpleasant method – compliance is small. In addition, these therapies get months to operate from the onset of cure. The enterprise suggests there are 7 million sufferers that have attempted and abandoned the common therapies.

Tyrvaya works by using a entirely new shipping and delivery strategy, as perfectly as a distinctive system of motion. It is utilised as a nasal fall, and it operates by triggering the trigeminal nerve which in its transform triggers tear manufacturing. In 3 clinical trials in around 1000 sufferers in gentle, reasonable and serious dry eye sickness – ONSET-1, ONSET-2 and MYSTIC – the drug has shown security and efficacy. Patients showed statistically substantial advancements in tear film production as assessed using the Schirmer’s score at Week 4, with much more than 50% individuals exhibiting optimal tear generation in comparison to about fifty percent that range in the placebo team:

TYRVAYA-addressed people confirmed statistically important improvements in tear movie production as assessed working with the anesthetized Schirmer’s score (-35 mm) at 7 days 4. Of the individuals dealt with with TYRVAYA, 52% attained ≥10 mm boost in Schirmer’s score from baseline in the ONSET-1 review, and 47% realized ≥10 mm enhance in Schirmer’s rating from baseline in the ONSET-2 research, compared to 14% and 28% of motor vehicle-addressed sufferers in the ONSET-1 analyze and the ONSET-2 review, respectively at 7 days 4 (p<0.01 in both studies). Of the patients treated with TYRVAYA, the mean change in Schirmer's score was 11.7 mm and 11.3 mm as compared to 3.2 mm and 6.3 mm in the vehicle treated patients in the ONSET-1 study and ONSET-2 study, respectively at Week 4.

So the first full quarter revenue is $2.7mn. Around 19,000 prescriptions were filled, and these were written by 4500 unique prescribers. 65% of all patients went for refills. A number of patients have continued using the medicine for 6 months starting from November.

The company has also taken great strides on the mediclaim front. In February, TYRVAYA was placed on Express Scripts National Preferred basic and high performance formularies, which collectively make up around 26 million lives. The company has gone on to add more payers, and now it has commercial coverage for up to approximately 95 million lives, which represents 52% of all U.S. commercial lives.

Financials

OYST has a market cap of $134mn and a cash balance of $144mn. This is a terrible state of affairs. There’s a short interest of 22%, which says that the market still thinks the company is overvalued. For a commercial stage company with a clinically successful drug to be in this sorry state is unnerving for investors.

Sales and marketing expenses for the three months ended March 31, 2022, were $27.0 million, General and administrative expenses were $12.9 million, and Research and development expenses were $4.7 million. Net product revenues for the three months ended March 31, 2022, were $2.7 million. At this rate, and ignoring any major improvement in sales, the company hardly has cash for 2 more quarters.

In order to curtail some of these high expenses – high for a small company, that is – the company has gone through a restructuring process. This, it says, will lead to $6M-$8M in savings this year but also include laying off up to 50 workers. The company expects savings of $40-$48mn in 2023. These measures will allow it to commercialize Tyrvaya better, and also put focus on the NK pipeline program. This plan will also include retiring John Snisarenko, Chief Commercial Officer, effective July 1.

The company signed a deal with a Chinese firm last year to commercialize Tyrvaya in China against $17.5mn in upfront payment and a stake in that Chinese company.

Bottom Line

I really have nothing to say. Restasis is a billion dollar drug, while Xiidra is a half-a-billion dollar drug. Tyrvaya has an admittedly better mechanism of action and mode of delivery. Yet it is floundering in the market, and I cannot find any reason for that except perhaps lack of execution, which is also difficult to allege given what the company has been doing. All in all, this is a perplexing situation, and when I am perplexed, I tend to avoid buying.

About the TPT service

Thanks for reading. At the Total Pharma Tracker, we offer the following:-


Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. 

For investors requiring hands-on support, our in-house experts go through our tools and find the best investible stocks, complete with buy/sell strategies and alerts.

Sign up now for our free trial, request access to our tools, and find out, at no cost to you, what we can do for you. 

Tags: Amazon Business Login, Amazon Business Prime, Bank Of America Business Account, Best Business Schools, Business Attorney Near Me, Business Bank Account, Business Card Holder, Business Card Maker, Business Card Template, Business Cards Near Me, Business Casual Attire, Business Casual Shoes, Business Casual Woman, Business Plan Examples, Ca Business Search, Ca Sos Business Search, Capital One Business Credit Card, Chase Business Checking, Chase Business Credit Cards, Chase Business Customer Service, Chase Business Login, Chase Business Phone Number, Cheap Business Cards, Citizens Business Bank, Cox Business Login, Digital Business Card, Facebook Business Suite, Finance In Business, Free Business Cards, Google Business Login, Harvard Business School, Lands End Business, Massage Parlor Business Near Me, Michigan Business Entity Search, Mind Your Business, Mind Your Own Business, Ohio Business Search, Risky Business Costume, Skype For Business, Small Business Loan, Small Business Saturday 2021, Starting A Business, Texas Business Entity Search, Triumph Business Capital, Vending Machine Business, Verizon Business Customer Service, Vonage Business Login, Wells Fargo Business Account, Yahoo Small Business, Yahoo Small Business Login

Continue Reading

Previous UK finance minister Sunak’s resignation letter
Next Senegal sees growing support for African gas amid Ukraine war
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Apr    

Archives

Recent Posts

  • Winners and Losers in the China-US Trade War Truce
  • Mastering Risk Management in Financial Planning
  • Financial Planning Tips Every Investor Should Know
  • Trump vs Biden Debate Analysis: Who Came Out on Top?
  • The Most Controversial Moments From the Joe Biden Trump

BL

Tags

""Succeeded His Business"" 2 Of Cups Business 525 Business 5 Bankruptcies Accounting Business Letter To Client Att Business Login Bracken Business Communications Clinic Business Account No Deposit Business Administration Fafsa Business Balance Sheet Explained Business Card Business Card Printing La Plata Business Cards Media Bar Business Card To Secret Website Business Central Png Business Coaching Site Cloudfront Business Contract Lawyer 47201 Business Marketing Pearson Quizlet Business Milleage Leager 18 Business Mobile Broadand Plans Business Plan For Supplement Company Business Plan Loan Originayor Disrupting Digital Business Harvard Ffiec Business Continuity Templates Gauge Ear Piercing Business Good Openings For Business Letters Holton Investment Business Indianapolis Business Times Indiana Wesleyan University Business List Business In Search Engines List My Business Yahoo Lunch Susbcription Business Model Morgan Hill Business Liocense Renewal Nee Small Business Bill Signed Negotiating Business Acquisitions Practical Law Networking Trends Small Business New Business In Shorewood Il School Business Officer Being Unethical Small Business Administration Mass Small Business Comunity Small Business Corporation South Africa Small Business Depew Llc Small Business Medical Offices Chicago Small Business Office Lakewood Nj Small Business Plans Verizon Small Business Storage Array

Partner Links

prizebudgetforboys
carlospizzarestaurant

links

Capture Your Explore Snap
Roam Luxuriously with Suite Roam

BR

walnutagent
raisinagent

bp

backlinkplacement.com

mindbodybusiness.xyz | Magazine 7 by AF themes.

WhatsApp us